Viewing Study NCT06066359


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-25 @ 1:13 PM
Study NCT ID: NCT06066359
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2023-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module